510(k) Report

510(k) · Cleared

Cleared

Mardx Lyme Disease (Igg) Marblot Strip Test System

K950829510(k) TraditionalCleared Jun 5, 1996468-day reviewClass II21 CFR 866.3830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mardx Diagnostics, Inc. · LSR Reagent, Borrelia Serological Reagent

Cleared on Jun 5, 1996 after a 468-day review. The FDA summary names no predicate by number. 5 later devices descend from it.

Decided
Jun 5, 1996
Review
468 days
Class
Class II
Product code
LSR
Recalls
None
Predicates
0

5 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2012: 1 descendant cleared2003: 1 descendant cleared2017: 1 descendant cleared2021: 2 descendants clearedReference device: K894224 · Mardx Lyme Disease Eia (Igg) Test System · Mardx Diagnostics, Inc. · 19891995200020052010201520202025
  1. This deviceK950829 Mardx Lyme Disease (Igg) Marblot Strip Test SystemMardx Diagnostics, Inc. · 1996
  2. Descendant · cites it directly · 2 of its ownK113847 Borrelia Burgdorferi Igg Blot TestGold Standard Diagnostics · 2012
  3. Descendant · 2 generations on · 0 of its ownK203292 Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics · 2021
  4. Descendant · 2 generations on · 0 of its ownK203296 Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test KitGold Standard Diagnostics · 2021
  5. Descendant · cites it directly · 0 of its ownK163095 Lyme B. burgdorferi (IgG) MarStripe TestTrinity Biotech · 2017
  6. Descendant · cites it directly · 0 of its ownK032713 Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggBoston Biomedica, Inc. · 2003

Most influential descendants

Showing 5 of 5 · See all
  • K113847Borrelia Burgdorferi Igg Blot TestGold Standard Diagnostics · 2012 · cites it directly2descendants
  • K203292Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics · 2021 · 2 generations on0descendants
  • K203296Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test KitGold Standard Diagnostics · 2021 · 2 generations on0descendants
  • K163095Lyme B. burgdorferi (IgG) MarStripe TestTrinity Biotech · 2017 · cites it directly0descendants
  • K032713Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggBoston Biomedica, Inc. · 2003 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K950829Mardx Lyme Disease (Igg) Marblot Strip Test SystemMardx Diagnostics, Inc.1996—
+1K113847Borrelia Burgdorferi Igg Blot TestGold Standard Diagnostics2012—
+2K203292Gold Standard Diagnostics Borrelia burgdorferi IgG/IgM ELISA Test KitGold Standard Diagnostics2021—
+2K203296Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test KitGold Standard Diagnostics2021—
+1K163095Lyme B. burgdorferi (IgG) MarStripe TestTrinity Biotech2017—
+1K032713Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggBoston Biomedica, Inc.2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
201210
201710
202120
FIG. 1 — Lineage of K950829, 1996–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LSR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LSR device

  1. #1 K254295 Sofia Lyme FIA; Sofia 2 Campylobacter FIAscore 12.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113847Borrelia Burgdorferi Igg Blot TestGold Standard Diagnostics20122
K163095Lyme B. burgdorferi (IgG) MarStripe TestTrinity Biotech20170
K032713Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggBoston Biomedica, Inc.20030

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K113847 (Gold Standard Diagnostics, 2012) has gone furthest, with 2 descendants of its own.

How does its category compare?

All LSR devices

LSR Reagent, Borrelia Serological Reagent: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LSR

2in 2025

2007: 12008: 22009: 22010: 12012: 32013: 22015: 12016: 12017: 62018: 32019: 42020: 32021: 62022: 12023: 12024: 12025: 22026 (partial year): 1
2007high 6 (2017) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LSR

133in 2021

2012: 155 days median2017: 150 days median2018: 92 days median2019: 86 days median2020: 91 days median2021: 133 days median
2007high 155 (2012) · low 86 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LSR

1in 2025

2013: 12021: 22025: 1
2007high 2 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LSR

1in 2025

2008: 22011: 12014: 532015: 252016: 102017: 92018: 42019: 152020: 72021: 42022: 12023: 22025: 1
2007high 53 (2014) · low 0 (2007)2025

MAUDE reports naming product code LSR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—02
20092—00
20101—00
20110—01
2012315500
20132—10
20140—053
20151—025
20161—010
2017615009
201839204
2019486015
202039107
2021613324
20221—01
20231—02
20241—00
20252—11
20261—0—

What is it indicated for?

MarDx Lyme Disease (IgG) Marblot Strip Test System is a Western blot assay for the qualitative detection of human IgG antibody to B. burgdorferi. The MarDx Lyme Disease (IgG) Marblot Strip Test System is intended for use in testing human serum samples which have been found positive or equivocal using an EIA or [FA test procedure.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K950829: Mardx Lyme Disease (Igg) Marblot Strip Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K950829

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026